Covid-19: HIV drugs can be used in severe cases, says ICMR | Delhi News - Times of India
Long-Term Treatment with Lopinavir-Ritonavir Induces a Reduction in Peripheral Adipose Depots in Mice | Antimicrobial Agents and Chemotherapy
Ritonavir - Patient | NIH
Frontiers | High Dose Lopinavir/Ritonavir Does Not Lead to Sufficient Plasma Levels to Inhibit SARS-CoV-2 in Hospitalized Patients With COVID-19
Lopinavir/Ritonavir (LPV/r, Kaletra)
Lopinavir - an overview | ScienceDirect Topics
Once-daily reduced dose darunavir/ritonavir (400 mg/100 mg) is non-inferior to twice-daily lopinavir/ritonavir in South African switch study | HTB | HIV i-Base
Use of WHO paediatric weight-band dosing in drug labels - The Lancet HIV
Randomised Pharmacokinetic Trial of Rifabutin with Lopinavir/Ritonavir-Antiretroviral Therapy in Patients with HIV-Associated Tuberculosis in Vietnam | PLOS ONE
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use KALETRA safely and effec
PulmCrit - Preview of Lopinavir/Ritonavir efficacy in COVID-19?
Pharmacokinetic Interactions Between Quinine and Lopinavir/Ritonavir in Healthy Thai Adults in: The American Journal of Tropical Medicine and Hygiene Volume 93 Issue 6 (2015)
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19 | NEJM
Randomised Pharmacokinetic Trial of Rifabutin with Lopinavir/Ritonavir-Antiretroviral Therapy in Patients with HIV-Associated Tuberculosis in Vietnam | PLOS ONE
Low-Dose Lopinavir/Ritonavir Tablet Noninferior to Full Dose in Thai Children
Low-dose versus standard-dose ritonavir-boosted atazanavir in virologically suppressed Thai adults with HIV (LASA): a randomised, open-label, non-inferiority trial - The Lancet HIV
Lopinavir metered-dose transdermal spray through microporated skin: Permeation enhancement to achieve therapeutic needs - ScienceDirect
Low-Dose Lopinavir/Ritonavir Tablet Noninferior to Full Dose in Thai Children
N21-226S040; 21-906S42; 21-251S049 Lopinavir/ritonavir PREA
NORVIR Dosage & Rx Info | Uses, Side Effects
Low-Dose Lopinavir/Ritonavir Tablet Noninferior to Full Dose in Thai Children
Lopinavir and Ritonavir Capsule, Tablet and Oral Solution
Experimental COVID-19 Therapy Combination Lopinavir/Ritonavir Is Implicated in a Complicated Set of Drug-Drug Interactions - Anesthesia Patient Safety Foundation
Association of lopinavir concentrations with plasma lipid or glucose concentrations in HIV-infected South Africans: a cross sectional study | AIDS Research and Therapy | Full Text
Lower-dose lopinavir/ritonavir reduces side-effects, maintains viral control in Thai children | aidsmap
Reduced dose darunavir/ritonavir effective and safe for people switching while virally suppressed | aidsmap
Frontiers | High Dose Lopinavir/Ritonavir Does Not Lead to Sufficient Plasma Levels to Inhibit SARS-CoV-2 in Hospitalized Patients With COVID-19